首页> 外国专利> Transplantable neural progenitors and stem cells for treatment of brain tumors

Transplantable neural progenitors and stem cells for treatment of brain tumors

机译:可移植神经祖细胞和干细胞治疗脑肿瘤

摘要

One of the impediments to the treatment of some human brain tumors (e.g., gliomas) has been the degree to which they expand, migrate widely, and infiltrate normal tissue. We demonstrate that a clone of multipotent neural progenitor stem cells, when implanted into an experimental glioma, will migrate along with and distribute themselves throughout the tumor in juxtaposition to widely expanding and aggressively advancing tumor cells, while continuing to express a foreign reporter gene. Furthermore, drawn somewhat by the degenerative environment created just beyond the infiltrating tumor edge, the neural progenitor cells migrate slightly beyond and surround the invading tumor border. When implanted at a distant site from the tumor bed (e.g., into normal tissue, into the contralateral hemisphere, into the lateral ventricles) the donor neural progenitor/stem cells will migrate through normal tissue and specifically target the tumor cells. These results suggest the adjunctive use of neural progenitor/stem cells as a novel, effective delivery vehicle for helping to target therapeutic genes and vectors to invasive brain tumors that have been refractory to treatment.
机译:治疗某些人脑肿瘤(例如神经胶质瘤)的障碍之一是它们扩展,广泛迁移和浸润正常组织的程度。我们证明,多能神经祖干细胞的克隆,当植入实验性神经胶质瘤中时,将与肿瘤一起迁移并在整个肿瘤中并列分布,从而广泛扩散并积极推进肿瘤细胞,同时继续表达外源报道基因。此外,神经祖细胞略微被超出浸润性肿瘤边缘的退化环境所吸引,因此略微移出并围绕侵入的肿瘤边界。当植入远离肿瘤床的位置(例如植入正常组织,对侧半球,侧脑室)时,供体神经祖细胞/干细胞将迁移通过正常组织,并特异性靶向肿瘤细胞。这些结果表明,神经祖细胞/干细胞作为一种新型,有效的递送载体的辅助用途,有助于将治疗基因和载体靶向难治性的浸润性脑肿瘤。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号